(Q64115484)

2

0 references

Ying Zhou

3

0 references

Yong Huang

4

0 references

Ping Liang

5

0 references

Tao Cheng

6

0 references

Long Chen

7

0 references

Le-Qun Li

8

0 references

Shi-Xiong Liang

Creative Commons Attribution 4.0 International

9

0 references

language of work or name

English

0 references

publication date

27 March 2019

0 references

published in

Radiation Oncology

0 references

volume

14

0 references

issue

1

0 references

page(s)

50

0 references

copyright license

start time

27 March 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/s13014-019-1251-y

0 references

cites work

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

12 December 2020

Hepatobiliary cancers, version 2.2014.

1 reference

12 December 2020

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade

1 reference

12 December 2020

Analysis of risk and predictors of brain radiation necrosis after radiosurgery

1 reference

12 December 2020

Stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma in 132 Chinese patients

1 reference

12 December 2020

Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma

1 reference

12 December 2020

A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma.

1 reference

12 December 2020

The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.

1 reference

12 December 2020

ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.

1 reference

12 December 2020

Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm

1 reference

12 December 2020

Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer

1 reference

12 December 2020

Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation

1 reference

12 December 2020

Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma

1 reference

12 December 2020

Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.

1 reference

12 December 2020

Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy

1 reference

12 December 2020

Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score.

1 reference

12 December 2020

Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function.

1 reference

12 December 2020

A prospective cohort study of hepatic toxicity after stereotactic body radiation therapy for hepatocellular carcinoma

1 reference

12 December 2020

Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT)

1 reference

12 December 2020